WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 15-July-2016 (15-July-2016)
Next overall update Fall 2016
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 2'7001 Infant (under 12 months) mortality rate: 452
GDP / capita (US$): 6'3501 Child (under 5 years) mortality rate: 612

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 1'287  1'269  1'251  1'232  1'212  1'064  863  603 
Births 38  38  38  37  37  34  37  29 
Surviving infants 35  35  35  35  35  31  34  26 
Pop. less than 5 years 173  172  171  170  168  157  166  119 
Pop. less than 15 years 481  477  473  470  467  474  415  294 
Female 15-49 years 334  329  324  318  313  259  207  138 

Number of reported cases

(Click for retrospective incidence data for Swaziland)
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  10  1'465 
Mumps
ChartChart
  10'730  6'773 
Pertussis
ChartChart
  20 
Polio*
ChartChart
  192 
Rubella
ChartChart
  110  23  20  115 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Swaziland)
Vaccine year result method % card seen                                                
BCG 2011  91  EPI   85  98  99  99  68  98  90  96 
DTP1 2011  89  EPI   85  96  99  99  97  98  99* 
DTP3 2011  88  EPI   85  90  98  98  95  91  98  89 
DTP4         
IPV1         
HepB_BD         
HepB3 2011  88  EPI   85  98  98  95  91 
Hib3 2011  88  EPI   85  90  98  98  95  91 
JapEnc         
MCV1          89  97  97  88  98  80  85 
MCV2          73  89  89  52  74 
PCV1          81  90 
PCV3          80  89 
Pol3 2011  88  EPI   85  84  98  98  92  85  97  89 
Rota1          74 
RotaC          72 
Rubella1         
TT2plus 2011  61  EPI   85  57  72  72  53  79  94  76 
PAB         
VAD1          14  92  92  41  23 
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Swaziland)
BCG
ChartChart
  98  99  99  99  98  88  96 
DTP1
ChartChart
  96  99  99  97  98  94  96 
DTP3
ChartChart
  90  98  98  95  91  84  89 
HepB3
ChartChart
  98  98  98  95  91  83 
HepB_BD
ChartChart
 
Hib3
ChartChart
  90  98  98  95  91 
IPV1
ChartChart
 
MCV1
ChartChart
  78  86  85  77  87  92  85 
MCV2
ChartChart
  89  89  89  52  92 
PAB
ChartChart
  88  88  86  86  86  80  63 
PCV3
ChartChart
  88  67 
Pol3
ChartChart
  98  98  98  92  85  87  89 
RCV1
ChartChart
 
RotaC
ChartChart
  36 

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 0
From 80 to 89% 100
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 5 years; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HepB 1st contact; +1, +2 months; Yes health care workers
Measles 9, 18 months; Yes
OPV birth; 6, 10, 14 weeks; 18 months; 5 years; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
TT 1st contact pregnancy; +1, +6 months; +1,+1 years; 15-49 years
VitaminA 6, 12, 18, 24, 30, 36 months; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2012-2016  2012-2016  2007-2011  2007 - 2011  2007 - 2011  2007 - 2011 
Nº of districts with microplans that include activities to raise immunization coverage number

System performance

Total Nº districts in country number
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 75  25  25  100  50 
Nº districts with measles (MCV1) coverage >=95% number  
% of districts with MCV1 coverage >=95% From 0 to 100%   25 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  No  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 97  97  50  48  90  90 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.